Theravance Biopharma
TBPH
TBPH
115 hedge funds and large institutions have $655M invested in Theravance Biopharma in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 23 closing their positions.
Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
49
Reduced
28
Closed
23
Calls
$978K
Puts
$4.14M
Net Calls
-$3.17M
Net Calls Change
-$7.13M
Top Buyers
| 1 |
WAM
1
Weiss Asset Management
Boston,
Massachusetts
|
$28.8M |
| 2 |
MAP
2
Madison Avenue Partners
New York
|
$73.5M |
| 3 |
3
Morgan Stanley
New York
|
$16.3M |
| 4 |
NM
4
Newtyn Management
New York
|
$11.1M |
| 5 |
5
D.E. Shaw & Co
New York
|
$9.68M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ECM
126
ExodusPoint Capital Management
New York
| – | -$109K | -14,791 | Closed |
|
|
DT
127
Diversified Trust
Memphis,
Tennessee
| – | -$109K | -14,721 | Closed |
|
128
Handelsbanken Fonder
Stockholm,
Sweden
| – | -$100K | -13,516 | Closed |
|
129
Rafferty Asset Management
New York
| – | -$94K | -12,649 | Closed |
|
130
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$52 | -7,000 | Closed |
|
|
PCM
131
Penserra Capital Management
Orinda,
California
| – | -$12K | -1,685 | Closed |
|
|
PHK
132
Point72 Hong Kong
Hong Kong
| – | -$6K | -775 | Closed |
|
133
Nomura Holdings
Tokyo,
Japan
| – | -$3K | -352 | Closed |
|